These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 26220939)

  • 1. Association between α-synuclein blood transcripts and early, neuroimaging-supported Parkinson's disease.
    Locascio JJ; Eberly S; Liao Z; Liu G; Hoesing AN; Duong K; Trisini-Lipsanopoulos A; Dhima K; Hung AY; Flaherty AW; Schwarzschild MA; Hayes MT; Wills AM; Shivraj Sohur U; Mejia NI; Selkoe DJ; Oakes D; Shoulson I; Dong X; Marek K; Zheng B; Ivinson A; Hyman BT; Growdon JH; Sudarsky LR; Schlossmacher MG; Ravina B; Scherzer CR
    Brain; 2015 Sep; 138(Pt 9):2659-71. PubMed ID: 26220939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 123I-FP-CIT SPECT [(123) I-2β-carbomethoxy-3β-(4-iodophenyl)-N-(3-fluoropropyl) nortropane single photon emission computed tomography] Imaging in a p.A53T α-synuclein Parkinson's disease cohort versus Parkinson's disease.
    Koros C; Simitsi A; Prentakis A; Beratis I; Papadimitriou D; Kontaxopoulou D; Fragkiadaki S; Papagiannakis N; Seibyl J; Marek K; Papageorgiou SG; Trapali XG; Stamelou M; Stefanis L
    Mov Disord; 2018 Nov; 33(11):1734-1739. PubMed ID: 30288781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SNCA variants and alpha-synuclein level in CD45+ blood cells in Parkinson's disease.
    Emelyanov A; Kulabukhova D; Garaeva L; Senkevich K; Verbitskaya E; Nikolaev M; Andoskin P; Kopytova A; Milyukhina I; Yakimovskii A; Timofeeva A; Prakhova L; Ilves A; Vlasova I; Pchelina S
    J Neurol Sci; 2018 Dec; 395():135-140. PubMed ID: 30316070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does α-synuclein have a dual and opposing effect in preclinical vs. clinical Parkinson's disease?
    Markopoulou K; Biernacka JM; Armasu SM; Anderson KJ; Ahlskog JE; Chase BA; Chung SJ; Cunningham JM; Farrer M; Frigerio R; Maraganore DM
    Parkinsonism Relat Disord; 2014 Jun; 20(6):584-9; discussion 584. PubMed ID: 24656894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Somatic copy number gains of α-synuclein (SNCA) in Parkinson's disease and multiple system atrophy brains.
    Mokretar K; Pease D; Taanman JW; Soenmez A; Ejaz A; Lashley T; Ling H; Gentleman S; Houlden H; Holton JL; Schapira AHV; Nacheva E; Proukakis C
    Brain; 2018 Aug; 141(8):2419-2431. PubMed ID: 29917054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk variants of the α-synuclein locus and REM sleep behavior disorder in Parkinson's disease: a genetic association study.
    Bjørnarå KA; Pihlstrøm L; Dietrichs E; Toft M
    BMC Neurol; 2018 Feb; 18(1):20. PubMed ID: 29466944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood RNA biomarkers in prodromal PARK4 and rapid eye movement sleep behavior disorder show role of complexin 1 loss for risk of Parkinson's disease.
    Lahut S; Gispert S; Ömür Ö; Depboylu C; Seidel K; Domínguez-Bautista JA; Brehm N; Tireli H; Hackmann K; Pirkevi C; Leube B; Ries V; Reim K; Brose N; den Dunnen WF; Johnson M; Wolf Z; Schindewolf M; Schrempf W; Reetz K; Young P; Vadasz D; Frangakis AS; Schröck E; Steinmetz H; Jendrach M; Rüb U; Başak AN; Oertel W; Auburger G
    Dis Model Mech; 2017 May; 10(5):619-631. PubMed ID: 28108469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variants in the SNCA gene associate with motor progression while variants in the MAPT gene associate with the severity of Parkinson's disease.
    Wang G; Huang Y; Chen W; Chen S; Wang Y; Xiao Q; Liu J; Fung VS; Halliday G; Chen S
    Parkinsonism Relat Disord; 2016 Mar; 24():89-94. PubMed ID: 26776090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Homozygous alpha-synuclein p.A53V in familial Parkinson's disease.
    Yoshino H; Hirano M; Stoessl AJ; Imamichi Y; Ikeda A; Li Y; Funayama M; Yamada I; Nakamura Y; Sossi V; Farrer MJ; Nishioka K; Hattori N
    Neurobiol Aging; 2017 Sep; 57():248.e7-248.e12. PubMed ID: 28666710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [SNCA rs356219 AND rs356165 VARIANTS ARE ASSOCIATED WITH PARKINSON'S DISEASE AND INCREASED ALPHA-SYNUCLEIN GENE EXPRESSION IN THE CD45(+)-BLOOD CELLS].
    Emelyanov AK; Andoskin PA; Miliukhina IV; Timofeeva AA; Yakimovskii AF; Senkevich KA; Nikolaev MA; Pchelina SN
    Tsitologiia; 2016; 58(2):99-104. PubMed ID: 27228655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and neuroimaging features of patient with early-onset Parkinson's disease with dementia carrying SNCA p.G51D mutation.
    Tokutake T; Ishikawa A; Yoshimura N; Miyashita A; Kuwano R; Nishizawa M; Ikeuchi T
    Parkinsonism Relat Disord; 2014 Feb; 20(2):262-4. PubMed ID: 24315198
    [No Abstract]   [Full Text] [Related]  

  • 12. Integrated Plasma and Neuroimaging Biomarkers Associated with Motor and Cognition Severity in Parkinson's Disease.
    Chen CH; Lee BC; Lin CH
    J Parkinsons Dis; 2020; 10(1):77-88. PubMed ID: 31868681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Relationship between alpha-synuclein and Parkinson's disease].
    Nishioka K; Hattori N
    Brain Nerve; 2007 Aug; 59(8):825-30. PubMed ID: 17713118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of the Parkinson's Disease-Associated Gene Alpha-Synuclein is Regulated by the Neuronal Cell Fate Determinant TRIM32.
    Pavlou MAS; Colombo N; Fuertes-Alvarez S; Nicklas S; Cano LG; Marín MC; Goncalves J; Schwamborn JC
    Mol Neurobiol; 2017 Aug; 54(6):4257-4270. PubMed ID: 27339877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parkinson's disease correlates with promoter methylation in the α-synuclein gene.
    Pihlstrøm L; Berge V; Rengmark A; Toft M
    Mov Disord; 2015 Apr; 30(4):577-80. PubMed ID: 25545759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parkinson disease: α-synuclein mutational screening and new clinical insight into the p.E46K mutation.
    Pimentel MM; Rodrigues FC; Leite MA; Campos Júnior M; Rosso AL; Nicaretta DH; Pereira JS; Silva DJ; Della Coletta MV; Vasconcellos LF; Abreu GM; Dos Santos JM; Santos-Rebouças CB
    Parkinsonism Relat Disord; 2015 Jun; 21(6):586-9. PubMed ID: 25817515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. REM behavior disorder predicts motor progression and cognitive decline in Parkinson disease.
    Pagano G; De Micco R; Yousaf T; Wilson H; Chandra A; Politis M
    Neurology; 2018 Sep; 91(10):e894-e905. PubMed ID: 30089615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of rs3910105 in the Synuclein Gene on Dopamine Transporter Availability in Healthy Subjects.
    Seo Y; Pak K; Nam HY; Seok JW; Lee MJ; Kim EJ; Lee JM; Kim SJ; Kim IJ
    Yonsei Med J; 2018 Aug; 59(6):787-792. PubMed ID: 29978616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. α-synuclein expression from a single copy transgene increases sensitivity to stress and accelerates neuronal loss in genetic models of Parkinson's disease.
    Cooper JF; Spielbauer KK; Senchuk MM; Nadarajan S; Colaiácovo MP; Van Raamsdonk JM
    Exp Neurol; 2018 Dec; 310():58-69. PubMed ID: 30194957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical heterogeneity of alpha-synuclein gene duplication in Parkinson's disease.
    Nishioka K; Hayashi S; Farrer MJ; Singleton AB; Yoshino H; Imai H; Kitami T; Sato K; Kuroda R; Tomiyama H; Mizoguchi K; Murata M; Toda T; Imoto I; Inazawa J; Mizuno Y; Hattori N
    Ann Neurol; 2006 Feb; 59(2):298-309. PubMed ID: 16358335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.